UNH Q2 2016 Earnings Report — UnitedHealth Group Incorporated Revenue & Financial Results | Market Cap Arena

UnitedHealth Group IncorporatedUNH

Q2 2016 Earnings

Reported August 2, 2016

Quarter Comparison

Revenue

Operating Income

Gross Margin

Net Margin

EPS (Diluted)

Free Cash Flow

Metric	Q2 2016	Q1 2016	Q2 2015	QoQ Change	YoY Change
Revenue	$46.5B	$44.5B	—	4.4%	—
Op. Income	$3.2B	$3.0B	—	8.2%	—
Gross Margin	22.6%	23.0%	—	-0.3pp	—
Net Margin	3.8%	3.6%	—	0.2pp	—
EPS (Diluted)	$1.81	$1.67	—	8.4%	—
Free Cash Flow	$1.3B	$1.9B	—	-31.6%	—

Revenue Flow

Item	Amount
REVENUE	$46.5B
Cost of Revenue	$36.0B
GROSS PROFIT	$10.5B
R&D Expenses	$0
Selling & Marketing	$0
General & Administrative	$0
SG&A Expenses	$0
Other Expenses	$7.3B
Operating Expenses	$7.3B
Cost & Expenses	$43.3B
OPERATING INCOME	$3.2B
Interest Income	$0
Interest Expense	$271M
Other Income/Expenses	-$271M
INCOME BEFORE TAX	$2.9B
Income Tax Expense	$1.2B
Net Income from Continuing Ops	$1.8B
Net Income from Discontinued Ops	$0
Other Adjustments	$0
NET INCOME	$1.8B
Net Income Deductions	$0
BOTTOM LINE NET INCOME	$1.8B
D&A	$511M
EBIT	$3.2B
EBITDA	$3.7B
EPS	$2
EPS Diluted	$2

Income Statement

Item	Amount
REVENUE	$46.5B
Cost of Revenue	$36.0B
GROSS PROFIT	$10.5B
R&D Expenses	$0
Selling & Marketing	$0
General & Administrative	$0
SG&A Expenses	$0
Other Expenses	$7.3B
Operating Expenses	$7.3B
Cost & Expenses	$43.3B
OPERATING INCOME	$3.2B
Interest Income	$0
Interest Expense	$271M
Other Income/Expenses	-$271M
INCOME BEFORE TAX	$2.9B
Income Tax Expense	$1.2B
Net Income from Continuing Ops	$1.8B
Net Income from Discontinued Ops	$0
Other Adjustments	$0
NET INCOME	$1.8B
Net Income Deductions	$0
BOTTOM LINE NET INCOME	$1.8B
D&A	$511M
EBIT	$3.2B
EBITDA	$3.7B
EPS	$2
EPS Diluted	$2

Cash Flow Statement

Item	Amount
Net Income	$1.8B
Depreciation & Amortization	$511M
Stock-Based Compensation	$105M
Deferred Income Tax	-$312M
Other Non-Cash Items	$0
Change in Working Capital	-$381M
OPERATING CASH FLOW	$1.7B
Capital Expenditure	-$388M
Acquisitions (Net)	-$338M
Purchases of Investments	-$1.5B
Sales/Maturities of Investments	$2.3B
Other Investing Activities	-$2.3B
NET CASH FROM INVESTING	-$2.2B
Net Debt Issuance	-$591M
Common Stock Repurchased	-$480M
Common Dividends Paid	-$594M
Other Financing Activities	-$252M
NET CASH FROM FINANCING	-$1.9B
FREE CASH FLOW	$1.3B
Net Change in Cash	-$2.4B

Balance Sheet

Item	Amount
Cash & Equivalents	$8.2B
Short-Term Investments	$2.8B
Net Receivables	$16.7B
Inventory	$0
Other Current Assets	$5.6B
TOTAL CURRENT ASSETS	$33.3B
PP&E (Net)	$5.2B
Goodwill	$46.9B
Intangible Assets	$8.9B
Long-Term Investments	$22.2B
Tax Assets	$2.9B
Other Non-Current Assets	$289M
TOTAL NON-CURRENT ASSETS	$86.3B
TOTAL ASSETS	$119.6B
Account Payables	$31.0B
Short-Term Debt	$6.4B
Deferred Revenue	$1.6B
Other Current Liabilities	$8.4B
TOTAL CURRENT LIABILITIES	$47.4B
Long-Term Debt	$26.8B
Deferred Revenue NC	-$2.9B
Deferred Tax Liabilities	$2.9B
Other Non-Current Liabilities	$7.4B
TOTAL NON-CURRENT LIABILITIES	$34.2B
TOTAL LIABILITIES	$81.6B
Common Stock	$10M
Additional Paid-In Capital	$0
Retained Earnings	$38.6B
Treasury Stock	$0
Accum. Other Comp. Income	-$2.2B
Other Equity	$0
TOTAL STOCKHOLDERS' EQUITY	$36.4B
Minority Interest	$1.6B
TOTAL EQUITY	$38.0B
TOTAL LIABILITIES & EQUITY	$119.6B
Total Debt	$33.2B
Net Debt	$25.0B